Abstracts tagged "Biologic agents and tuberculosis"

Abstract Number: 2157 • 2014 ACR/ARHP Annual Meeting
Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases
Bunyamin Kisacik¹, Omer Pamuk², Ahmet Mesut Onat³, B. Erer⁴, Gulen Hatemi⁵, Yesim Ozguler⁶, Yavuz Pehlivan⁷, Levent Kilic⁸, Ihsan Ertenli⁸, Meryem Can⁹, Haner Direskeneli⁹, Gökhan Keser¹⁰, Fahrettin Oksel¹⁰, Ediz Dalkilic¹¹, Sedat Yilmaz¹², Salih Pay¹³, Ayse Balkarli¹⁴, Veli Cobankara¹⁵, Gozde Yildirim Cetin¹⁶, Mehmet Sayarlioglu¹⁷, Ayse Cefle¹⁸, Ayten Yazici¹⁸, Ali Berkant Avci¹⁹, Ender Terzioglu²⁰, Suleyman Ozbek²¹, Servet Akar²² and Ahmet Gül²³, ¹Rheumatology, Gaziantep University, School of Medicine, Gaziantep, Turkey, ²Trakya Üniversitesi, edirne, Turkey, ³Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁴Istanbul Faculty of Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ⁵Istanbul University, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, ⁶University of Istanbul, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, ⁷Rheumatology, Uludag University, School of Medicine, Bursa, Turkey, ⁸Hacettepe Üniversity, Ankara, Turkey, ⁹Marmara Üniversitesi, Ýstanbul, Turkey, ¹⁰Ege Üniversitesi, Ýzmir, Turkey, ¹¹Uludað Üniversitesi, Bursa, Turkey, ¹²GATA, ANKARA, Turkey, ¹³GATA, Ankara, Turkey, ¹⁴Pamukkale Üniversitesi, Denizli, Turkey, ¹⁵Denizli Üniversitesi, Denizli, Turkey, ¹⁶Deparment of Rheumatology, Sutcu Imam University, School of Medicine, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey, ¹⁷Rheumatology, Ondokuz Mayis University School of Medicine, Samsun, Turkey, ¹⁸Department of Rheumatology, Kocaeli University, Kocaeli, Turkey, ¹⁹Antalya University, School of Medicine, Department of Internal Medicine, Division of Rheumatology, Antalya, Turkey, ²⁰School of Medicine, Akdeniz University, Antalya, Turkey, ²¹Cukurova Üniversitesi, Adana, Turkey, ²²Katip Çelebi Üniversitesi, Ýzmir, Turkey, ²³Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
Background/Purpose Tumor necrosis factor alpha inhibitors (anti-TNF) are a breakthrough for the treatment of inflammatory rheumatic diseases and tuberculosis (TB) is the prevailing and vitally…
Abstract Number: 1324 • 2013 ACR/ARHP Annual Meeting
Evaluation Of The Usefulness Of Interferon-Gamma Release Assays and Tuberculin Skin Test For Detection Of Latent Mycobacterium Tuberculosis Infection In Korean Rheumatic Patients With Biologic Agents
Jae-Hoon Kim¹, Soyoung Won², Chan-Bum Choi³, Yoon-Kyoung Sung⁴, Gwan Gyu Song¹ and Sang-Cheol Bae⁵, ¹Div of Rheum, Dept of Int Med, Korea Univ College of Med, Seoul, South Korea, ²Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, ³Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, ⁴Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ⁵Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea
Background/Purpose: The screening for and treatment of latent tuberculosis infection (LTBI) before starting biologic agents is crucial to prevent reactivation and resultant serious infection. Several…